PENTASA PROLONGED RELEASE TABLETS 1G

FERRING PHARMACEUTICALS PRIVATE LIMITED

FERRING PHARMACEUTICALS PRIVATE LIMITED

Therapeutic

Prescription Only

TABLET

**POSOLOGY AND METHOD OF ADMINISTRATION** Posology: **Ulcerative colitis** Treatment of active disease: Adults: Individual dosage, up to 4 g daily in divided doses. Children 6 years of age and older: Individual dosage, usually 20–30 mg/kg bodyweight daily in divided doses. Maintenance treatment: Adults: Individual dosage, usually 2 g daily in divided doses. Children 6 years of age and older: Individual dosage, usually 20–30 mg/kg bodyweight daily in divided doses. **Crohn’s disease** Treatment of active disease and maintenance treatment: Adults: Individual dosage, up to 4g daily in divided doses. Children 6 years of age and older: Individual dosage, usually 20–30 mg/kg bodyweight daily in divided doses. Paediatric population: There is only limited documentation for an effect in children (age 6–18 years). Method of administration: PENTASA® tablets must not be chewed. To facilitate swallowing, the tablets may be dispersed in 50 ml of cold water. Stir and drink immediately.